Allegiant Rx Blog
RxWIRE Newsletter – February 23, 2017
As oncologists race forward with new treatments verging on science fiction and biotech companies press on with drugs for once-hopeless rare disorders, one of the world’s most pervasive diseases looks like it’s been left behind.
Read MoreRxWIRE Newsletter – February 16, 2017
Managing pharmacy benefits has always been complex. As high-cost specialty drugs bring about unprecedented growth in spend and trend, the complexities and need to optimize program management have never been greater.
Read MoreRxWIRE Newsletter – February 9, 2017
In the face of a national backlash on drug prices, a handful of drugmakers have pledged to limit their prices on branded prescription drugs to 10% or less this year.
Read MoreRxWIRE Newsletter – February 3, 2017
Pharmaceutical Strategies Group, an integrated technology-enabled pharmacy solutions and cost-containment company, has rebranded its 340B solutions and will be unveiling PSG 340B Link™ at the 340B Coalition Winter Conference being held in San Francisco, CA, from February 1-3.
Read More